|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/56 | |
| A61P 15/00 |
| (11) | Patento numeris | 3054957 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14852485.3 |
| Europos patento paraiškos padavimo data | 2014-10-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-08-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-10-02 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/059443 |
| Data | 2014-10-07 |
| (87) | Numeris | WO 2015/054213 |
| Data | 2015-04-16 |
| (30) | Numeris | Data | Šalis |
| 201361887643 P | 2013-10-07 | US |
| (72) |
WOTTON, Paul K., US
JAFFE, Jonathan, US
|
| (73) |
Antares Pharma, Inc.,
100 Princeton South Corporate Center Suite 300, Ewing, NJ 08628,
US
|
| (54) | HEMATOCRIT MODULATION THROUGH NEEDLE ASSISTED JET INJECTION OF TESTOSTERONE |
| HEMATOCRIT MODULATION THROUGH NEEDLE ASSISTED JET INJECTION OF TESTOSTERONE |